Bruce Booth, Director at Kymera Therapeutics, Inc. (KYMR), sold 473,068 shares at $91.23 ($43.4M) on 2025-12-11, disclosed to the SEC on 2025-12-12.
Open-market sale of $43.4M KYMR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.64 | 31,459 | $2.8M | 6.4% |
| 2 | $88.64 | 5,979 | $530K | 1.2% |
| 3 | $88.64 | 5,979 | $530K | 1.2% |
| 4 | $88.64 | 31,459 | $2.8M | 6.4% |
| 5 | $89.25 | 3,391 | $303K | 0.7% |
| 6 | $89.25 | 3,391 |
| $303K |
| 0.7% |
| 7 | $89.25 | 17,825 | $1.6M | 3.7% |
| 8 | $89.25 | 17,825 | $1.6M | 3.7% |
| 9 | $90.14 | 2,001 | $180K | 0.4% |
| 10 | $90.14 | 2,001 | $180K | 0.4% |
| 11 | $90.14 | 10,545 | $951K | 2.2% |
| 12 | $90.14 | 10,545 | $951K | 2.2% |
| 13 | $92.41 | 47,349 | $4.4M | 10.1% |
| 14 | $92.41 | 47,349 | $4.4M | 10.1% |
| 15 | $92.41 | 9,060 | $837K | 1.9% |
| 16 | $92.41 | 9,060 | $837K | 1.9% |
| 17 | $93.20 | 16,338 | $1.5M | 3.5% |
| 18 | $93.20 | 16,338 | $1.5M | 3.5% |
| 19 | $93.20 | 85,862 | $8.0M | 18.4% |
| 20 | $93.20 | 85,862 | $8.0M | 18.4% |
| 21 | $91.23 | 976 | $89K | 0.2% |
| 22 | $91.23 | 976 | $89K | 0.2% |
| 23 | $91.23 | 5,125 | $468K | 1.1% |
| 24 | $91.23 | 5,125 | $468K | 1.1% |
| 25 | $91.04 | 108 | $10K | 0.0% |
| 26 | $91.04 | 570 | $52K | 0.1% |
| 27 | $91.04 | 570 | $52K | 0.1% |
| Total | $91.72 avg | 473,068 | $43.4M | 100% |
| Filing → |
| KYMR | SELL | 2026-06-30 | $56.5M | — | Filing → |
| KYMR | SELL | 2026-06-25 | $34.8M | — | Filing → |
| KYMR | SELL | 2026-06-25 | $44.0M | — | Filing → |